Human long pentraxin 3 expression system and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8883446
SERIAL NO

13387784

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an eukaryotic expression vector comprising a nucleotide sequence encoding for the human long pentraxin PTX3 protein under the control of an effective promoter and a nucleotide sequence encoding for a selectable marker, recombinant human cell able to provide expression of proteins encoded by the vector and method for the production of the human long pentraxin PTX3 protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S P AITALY ROME ROMA ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cassani, Giovanni Pavia, IT 11 64
Esposito, Adelaide Grumo Nevano, IT 1 2
Rivieccio, Vincenzo Torre del Greco, IT 1 2
Sassano, Marica Caserta, IT 4 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 11, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00